Full Text View
Tabular View
No Study Results Posted
Related Studies
Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
This study has been completed.
Study NCT00141323   Information provided by Ligand Pharmaceuticals

First Received on August 30, 2005.   Last Updated on August 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial